MET and hepatocellular carcinoma: Suppressing the downstream pathway of the HGF/MET axis, including phosphoinositide 3-kinase (PI3K)/AKT, RAS-RAF-MEK-ERK, and JAK/STAT, hinders the invasion and metastasis of hepatoma cells (74).